Sirona Biochem Corp V.SBM

New Press Release - Sirona Biochem Initiates GlycoProteMim(TM) Trademark for Anti-Aging Molecule TFC-1326

VANCOUVER, British Columbia, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF), is making a strategic move in the world of advanced skincare solutions. Today, the company announces the trademarking of its groundbreaking anti-aging and anti-wrinkle...read article.

[lscfa]

Why trademark via Brazilian agency?

[PeterG]

Good question. Maybe the first market where we sell AA? Why did they not mention how to finance the whole initiatives? We should already run out of cash. Maybe a new Financing will be announced today evening??

[biorun]

They had a bunch of cash come in from the tax credit. Many questions, few answers at this time.  By moving to trademark status on one of their pipelines, it looks to me like this signals a pivot on the business model.  I wonder if the work they are doing with Atheln is playing a role here. They are armed to the nuts with capability.

[MirrorWorldMan]

The question is why does Howie think this step is pivotal? Ignoring all the other useless self promoting claims of grandeur in the News Release, why does giving a molecule a name owned by Sirona vs calling it some letters and numbers?  Nothing changes, and the same incompetence remains in management when they try to sell a branded vs non-Branded compound.  My guess is Howie cannot make

[Turtle4]

The trademark means that there will be no exclusive license. Thats good, because sirona is not good in the negotiation of exclusive deals.

[lscfa]

Trademarking the molecule means no exclusive deals. Anyone can make a skin cream with Glycoprotemim inside. Allows maximum access to anti-aging cream market. 

[MirrorWorldMan]

Ahh, so Howie knows his former deals he announced with praise are in reality quite horrible, (Obagi, Wanbang, R+F, SkinMedica), is panicking because of his 10 yr lows in Share Price and decided to announce a new tactic with an over-inflated announcement.  Regardless of what great product SBM says they have... Can Howie scale it up and can Howie sell it?  How many more decades of

[lscfa]

Glycoprotemim reference back in May 2021.......      https://www.cafepharma.com/cpwire/article/Sirona-Biochems-Innovations-in-Biotechnology-Lead-to-Safer-More-Effective-Cosmetic-and-Pharmaceutical-Active-Ingredients-/404403-

[Haiduk]

What a meaningless update! They just informed that they were not able to strike a deal despite the fact that “The level of interest generated during BIO in June was exceptional”… Same story… with a different compound… What’s about the deal that “will make Sirona a profitable company”? GLTA

[forhandlaren]

Meaningless? Not able to strike a deal? Ignorant investor spreading misleading claims! In fact, it was an excellent news release. Most likely the anti-aging will open to be multiple deals and probably a race to the market. The remark about profitable company refers to the Abbvie deal once the product is launched.

[Haiduk]

Thank you for your reply and your valuable input, despite your unappropriated comments (to which I will refrain to answer). The company's track records speak for themselves (and do not hesitate to check my oldest posts that will invalidate my alleged “ignorance” of the company history). Please remind me about the outcome of the previous “deals” (Wangang, Obagi, R+F), as well as the other

[lscfa]

Trademarking must be in response to interest from the Bio Conference.... July 13, 2023 TFC-1326 – Anti-Aging Clinical Trial In April, we announced one of our most significant achievements to date: the successful completion of our clinical trial in anti-aging. Our compound, TFC-1326 surpassed our expectations, demonstrating remarkable benefits, including wrinkle reduction, diminished fine